久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實業(yè)有限公司Logo

熱門詞: 進口電動溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進口電動溫度調(diào)節(jié)閥數(shù)據(jù)表進口電動高溫調(diào)節(jié)閥-德國進口電動高溫法蘭調(diào)節(jié)閥進口電動蒸汽調(diào)節(jié)閥-德國進口電動蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁 > 所有品牌 > Wockhardt
Wockhardt
Wockhardt Wockhardt

印度制藥公司W(wǎng)ockhardt
Wockhardt Limited India,成立于1960年,印度最大的醫(yī)藥和生物科技企業(yè),該公司提供包括藥物配方,營養(yǎng)素產(chǎn)品和疫苗,活性藥物成份,以及生物制藥等領(lǐng)域的產(chǎn)品和服務(wù)。截止到2005年底該公司共有大約3500名員工,其中大約500名員工供職于海外分支機構(gòu)。Wockhardt還是印度唯一獲得“超級品牌”稱號的醫(yī)藥企業(yè),該稱號由國際組織“超級品牌理事會”頒發(fā)。


Wockhardt 和許多重要的制藥公司諸如Aventis, Amylin 以及 Astra Zeneca等組成了戰(zhàn)略聯(lián)盟。它在印度和英國都有分公司,這些分公司都接受美國FDA和英國MHRA的認證。


Preparing for change before change beckons. Harnessing the power of innovative research. Providing high-quality medicines for a healthier world. This is our world at Wockhardt.
Wockhardt is a global, pharmaceutical and biotechnology company that has grown by leveraging two powerful trends impacting the world of medicine - globalisation and biotechnology.

The Company has a market capitalisation of over US$ 1 billion and an annual turnover of US$ 650 million. Wockhardt’s pace of growth and momentum permeates every mindset, system and technology within the organisation.

Wockhardt today, is distinguished by a strong and growing presence in the world’s leading markets, with more than 65% of its revenue coming from Europe and the United States. Wockhardt’s market presence covers formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs).

The Company has its headquarters in India, and has
14 manufacturing plants in India, UK, Ireland, France and US
Subsidiaries in US, UK, Ireland and France
Marketing offices in Africa, Russia, Central and South East Asia.
 

Wockhardt has a strong track record in acquisition management, with five successful acquisitions in the European market. These acquisitions have strengthened Wockhardt’s position in the high-potential markets of Europe, and have expanded the global reach of the organisation.

Wockhardt Advantage

Wockhardt’s manufacturing facilities in India, UK, Ireland, France and US have the approval of major regulatory bodies, including US FDA and UK's MHRA, with capabilities for both Finished Dosage Formulations and APIs. The output includes

Steriles (Injectables)
Biopharmaceuticals
Orals (Tablets & Liquids)
Topicals (Creams & Ointments).


Wockhardt is a partner of choice for manufacturing, having entered into manufacturing alliances with leading pharmaceutical and biotechnology majors, including

Astra Zeneca Lab Aguettant
Aventis Amylin
Schering-Plough Eisai
Cell Therapeutics LSI, UK
AFT, New Zealand Ebewe, Austria

A key growth driver at Wockhardt is its state-of-the-art, multi-disciplinary research capability backed by a team of 500 skilled scientists. Consistent efforts have resulted in six breakthrough biotechnology products, 750+ patent filings and a pipeline of promising new molecules.

Wockhardt’s strategies are aligned towards being a significant player in the emerging global biopharmaceuticals market. In order to achieve this goal, the company has set up the Wockhardt Biotech Park, India’s largest biopharmaceuticals complex, with six dedicated plants built to international standards.

關(guān)于我們客戶服務(wù)產(chǎn)品分類法律聲明
主站蜘蛛池模板: 国模冰冰双人炮gogo | 日韩精品电影在线观看 | 欧美亚洲综合图区在线 | 欧美极品在线 | 国产国拍亚洲精品永久不卡 | 免费一区二区 | 国产成人精品一区二区 | 欧美日韩中文国产 | 国产成人精品aaaa视频一区 | 亚洲国产精久久久久久久 | 欧洲第一页 | 国产欧美日韩精品在钱 | 全免费一级午夜毛片 | 91精品国产高清久久久久久91 | 色妞综合 | 国产一区二区不卡视频 | 国产精品成人麻豆专区 | 国产一级一级一级成人毛片 | 人人爽人人草 | 在线播放一区 | www欧美在线观看 | 伊人精品视频 | 小处雏高清一区二区三区 | 久久99国产精品成人欧美 | 国产在线视频资源 | 一道精品视频一区二区三区男同 | 久久精品国产国产精品四凭 | 日本六十路丰满老太交尾 | 免费看黄色毛片 | 91亚洲国产成人久久精品网站 | 国产成人一区二区三区在线播放 | 欧美精品免费在线观看 | 91免费视频观看 | 国产一区亚洲欧美成人 | 亚洲第一页中文字幕 | 北条麻妃在线观看 | 边做边爱边吃奶叫床的视频 | 一级全黄毛片 | 毛片网此 | 综合伊人久久在一二三区 | 2021精品国内一区视频自线 |